The global lung cancer surgery market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The surgical instruments segment is expected to account for the largest share of the market in terms of revenue, followed by monitoring and visualization system and application segments. The surgical instruments segment is projected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030.
-The cost of lung cancer surgery can be expensive and may not be covered by insurance.
-There are many different types of lung cancers, which can make it difficult to diagnose and treat them all effectively.
Industry Growth Insights published a new data on “Lung Cancer Surgery Market”. The research report is titled “Lung Cancer Surgery Market research by Types (Surgical Instruments, Monitoring And Visualization System), By Applications (Lobectomy, Removal Of Sleeve, Regional Excision, Lung Removed All, Minimally Invasive Surgery), By Players/Companies Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz, Scanlan International, Trokamed”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lung Cancer Surgery Market Research Report
By Type
Surgical Instruments, Monitoring And Visualization System
By Application
Lobectomy, Removal Of Sleeve, Regional Excision, Lung Removed All, Minimally Invasive Surgery
By Companies
Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz, Scanlan International, Trokamed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Lung Cancer Surgery Market Report Segments:
The global Lung Cancer Surgery market is segmented on the basis of:
Types
Surgical Instruments, Monitoring And Visualization System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lobectomy, Removal Of Sleeve, Regional Excision, Lung Removed All, Minimally Invasive Surgery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Accuray
- Angiodynamics
- Ethicon
- Intuitive Surgical
- Olympus
- Teleflex
- Ackermann Instrumente
- Karl Storz
- Scanlan International
- Trokamed
Highlights of The Lung Cancer Surgery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical Instruments
- Monitoring And Visualization System
- By Application:
- Lobectomy
- Removal Of Sleeve
- Regional Excision
- Lung Removed All
- Minimally Invasive Surgery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lung Cancer Surgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lung cancer surgery is the most common type of surgery performed on patients with lung cancer. The goal of this type of surgery is to remove as much of the tumor as possible while preserving normal lung function.
Some of the key players operating in the lung cancer surgery market are Accuray, Angiodynamics, Ethicon, Intuitive Surgical, Olympus, Teleflex, Ackermann Instrumente, Karl Storz, Scanlan International, Trokamed.
The lung cancer surgery market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lung Cancer Surgery Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lung Cancer Surgery Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lung Cancer Surgery Market - Supply Chain
4.5. Global Lung Cancer Surgery Market Forecast
4.5.1. Lung Cancer Surgery Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lung Cancer Surgery Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lung Cancer Surgery Market Absolute $ Opportunity
5. Global Lung Cancer Surgery Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lung Cancer Surgery Market Size and Volume Forecast by Type
5.3.1. Surgical Instruments
5.3.2. Monitoring And Visualization System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lung Cancer Surgery Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lung Cancer Surgery Market Size and Volume Forecast by Application
6.3.1. Lobectomy
6.3.2. Removal Of Sleeve
6.3.3. Regional Excision
6.3.4. Lung Removed All
6.3.5. Minimally Invasive Surgery
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lung Cancer Surgery Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lung Cancer Surgery Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lung Cancer Surgery Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lung Cancer Surgery Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lung Cancer Surgery Demand Share Forecast, 2019-2026
9. North America Lung Cancer Surgery Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lung Cancer Surgery Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lung Cancer Surgery Market Size and Volume Forecast by Application
9.4.1. Lobectomy
9.4.2. Removal Of Sleeve
9.4.3. Regional Excision
9.4.4. Lung Removed All
9.4.5. Minimally Invasive Surgery
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lung Cancer Surgery Market Size and Volume Forecast by Type
9.7.1. Surgical Instruments
9.7.2. Monitoring And Visualization System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lung Cancer Surgery Demand Share Forecast, 2019-2026
10. Latin America Lung Cancer Surgery Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lung Cancer Surgery Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lung Cancer Surgery Market Size and Volume Forecast by Application
10.4.1. Lobectomy
10.4.2. Removal Of Sleeve
10.4.3. Regional Excision
10.4.4. Lung Removed All
10.4.5. Minimally Invasive Surgery
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lung Cancer Surgery Market Size and Volume Forecast by Type
10.7.1. Surgical Instruments
10.7.2. Monitoring And Visualization System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lung Cancer Surgery Demand Share Forecast, 2019-2026
11. Europe Lung Cancer Surgery Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lung Cancer Surgery Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lung Cancer Surgery Market Size and Volume Forecast by Application
11.4.1. Lobectomy
11.4.2. Removal Of Sleeve
11.4.3. Regional Excision
11.4.4. Lung Removed All
11.4.5. Minimally Invasive Surgery
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lung Cancer Surgery Market Size and Volume Forecast by Type
11.7.1. Surgical Instruments
11.7.2. Monitoring And Visualization System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lung Cancer Surgery Demand Share, 2019-2026
12. Asia Pacific Lung Cancer Surgery Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lung Cancer Surgery Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lung Cancer Surgery Market Size and Volume Forecast by Application
12.4.1. Lobectomy
12.4.2. Removal Of Sleeve
12.4.3. Regional Excision
12.4.4. Lung Removed All
12.4.5. Minimally Invasive Surgery
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lung Cancer Surgery Market Size and Volume Forecast by Type
12.7.1. Surgical Instruments
12.7.2. Monitoring And Visualization System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lung Cancer Surgery Demand Share, 2019-2026
13. Middle East & Africa Lung Cancer Surgery Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lung Cancer Surgery Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lung Cancer Surgery Market Size and Volume Forecast by Application
13.4.1. Lobectomy
13.4.2. Removal Of Sleeve
13.4.3. Regional Excision
13.4.4. Lung Removed All
13.4.5. Minimally Invasive Surgery
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lung Cancer Surgery Market Size and Volume Forecast by Type
13.7.1. Surgical Instruments
13.7.2. Monitoring And Visualization System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lung Cancer Surgery Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lung Cancer Surgery Market: Market Share Analysis
14.2. Lung Cancer Surgery Distributors and Customers
14.3. Lung Cancer Surgery Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Accuray
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Angiodynamics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ethicon
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Intuitive Surgical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Olympus
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Teleflex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ackermann Instrumente
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Karl Storz
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Scanlan International
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Trokamed
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
